# TC02 Obese Women Using It Morphine vs PCA IV Hydromorphone for Post-Cesarean Analgesia

> **NCT03282669** · PHASE4 · WITHDRAWN · sponsor: **Northwestern University**

## Conditions studied

- Pain, Postoperative
- Obesity
- Respiratory Insufficiency

## Interventions

- **DRUG:** Intrathecal Morphine
- **DRUG:** Intravenous hydromorphone

## Key facts

- **NCT ID:** NCT03282669
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-08
- **Primary completion:** 2021-12
- **Final completion:** 2021-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Change in institutional policy. Change in resources available.
- **Last updated:** 2022-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03282669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03282669, "TC02 Obese Women Using It Morphine vs PCA IV Hydromorphone for Post-Cesarean Analgesia". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03282669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*